| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 11/24/2005 | WO2005111623A1 Methods for diagnosis of acute myeloid leukemia |
| 11/24/2005 | WO2005111621A2 Molecular scaffolds for hiv-1 epitopes |
| 11/24/2005 | WO2005111213A1 Target gene mimitin of myc |
| 11/24/2005 | WO2005111208A1 Method of proliferating plasma cell |
| 11/24/2005 | WO2005111198A1 Cancerous disease modifying antibodies |
| 11/24/2005 | WO2005111196A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 11/24/2005 | WO2005111083A2 Antibodies specific for glycoprotein vi and methods of producing these antibodies |
| 11/24/2005 | WO2005111082A1 Anti-tfr antibody. |
| 11/24/2005 | WO2005111081A2 Immunoglobulin-like variable chain binding polypeptides and methods of use |
| 11/24/2005 | WO2005111080A2 Methods for reducing biofilm formation in infectious bacteria |
| 11/24/2005 | WO2005111079A2 Hiv vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-hiv-1 antibodies against the membrane proximal domain of hiv gp41 |
| 11/24/2005 | WO2005111078A2 Anti-cea scfv-beta-lactamase contructs (cab molecules) in adept |
| 11/24/2005 | WO2005111077A2 Methods for treating bone cancer pain by administering a nerve growth factor antagonist |
| 11/24/2005 | WO2005111066A2 Polypeptides from non-typeable haemophilus influenzae |
| 11/24/2005 | WO2005110490A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 11/24/2005 | WO2005110481A2 Prolongation of survival of an allograft by inhibiting complement activity |
| 11/24/2005 | WO2005110479A2 Treatments for pancreatic cancer |
| 11/24/2005 | WO2005110475A2 Antibodies |
| 11/24/2005 | WO2005110474A2 HUMANIZED FcϜRIIB SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
| 11/24/2005 | WO2005110472A1 Agent for actively restoring structure and functions of damaged tissues and organs |
| 11/24/2005 | WO2005110470A2 Methods and compositions for the modulation of immune responses and autoimmune diseases by activating rp105 (cd180) |
| 11/24/2005 | WO2005110459A2 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 11/24/2005 | WO2005110433A1 Nonhuman animal having expression of bach2 artificially inhibited, and use thereof |
| 11/24/2005 | WO2005110338A2 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | WO2005080431A3 Monoclonal antibodies that specifically bind to folate receptor alpha |
| 11/24/2005 | WO2005079844A3 Use for interleukin-33 (il33) and the il-33 receptor complex |
| 11/24/2005 | WO2005079267A3 Methods for protein production |
| 11/24/2005 | WO2005075515A3 Immunoglobulins and method for their modification |
| 11/24/2005 | WO2005073383A3 HETERODIMERIC FOLLICLE STIMULATING HORMONE-Fc (FSH-Fc) FUSION PROTEINS FOR THE TREATMENT OF INFERTILITY |
| 11/24/2005 | WO2005061547A3 Bispecific antibodies |
| 11/24/2005 | WO2005058358A3 Use of agents derived from ceacam1 for the treatment of inflammatory diseases |
| 11/24/2005 | WO2005051999A3 Substance binding human igg fc receptor iib |
| 11/24/2005 | WO2004070011A3 HIGH AFFINITY ANTI-HUMAN IgE ANTIBODIES |
| 11/24/2005 | WO2004045512A3 Human monoclonal antibodies against cd25 |
| 11/24/2005 | US20050262593 Antibody composition-producing cell |
| 11/24/2005 | US20050262577 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 11/24/2005 | US20050261489 Immune system disorders, cancer, viral diseases |
| 11/24/2005 | US20050261482 Regulation of human serine-threonine protein kinase |
| 11/24/2005 | US20050261480 Super humanized antibodies |
| 11/24/2005 | US20050261478 For activating T and/or B cells by aggregating three or more cell surface antigens; the activation signals may result in either immune enhancement or immunosuppression |
| 11/24/2005 | US20050261232 Non-natural ribonuclease conjugates as cytotoxic agents |
| 11/24/2005 | US20050261224 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 11/24/2005 | US20050261186 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 11/24/2005 | US20050261183 PTHrP-derived modulators of smooth muscle proliferation |
| 11/24/2005 | US20050261178 Administering to patient therapeutic dose of cytokine in combination with antibodies directed against tumor associated antigen carbonic anhydrase IX (CAIX/G250/MN); method characterized in significantly reduced cytokine-related toxicity combined with potentiated effectiveness of anti-G250 antibody alone |
| 11/24/2005 | US20050261175 monoclonal antibody immunoreactive with a stem cell factor; hybridoma cell line; can stimulate growth of primitive progenitors including early hematopoietic progenitor cells |
| 11/24/2005 | US20050261166 Compositions and methods for the therapy and diagnosis of lung cancer |
| 11/24/2005 | US20050260731 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 11/24/2005 | US20050260711 Modulating pH-sensitive binding using non-natural amino acids |
| 11/24/2005 | US20050260710 Methods for producing recombinant polyclonal immunoglobulins |
| 11/24/2005 | US20050260708 Proteases and protease inhibitors |
| 11/24/2005 | US20050260702 Novel integrin alpha subunit and uses thereof |
| 11/24/2005 | US20050260693 Tumor suppressor gene |
| 11/24/2005 | US20050260682 Compositions and methods for diagnosing or treating psoriasis |
| 11/24/2005 | US20050260681 Recovering autoantibodies/blood protein via adjustment in redox states for use in constructing profile for diagnosing autoimmune disorders; immunotherapy; antioxidant |
| 11/24/2005 | US20050260679 Reducing the risk of human anti-human antibodies through V gene manipulation |
| 11/24/2005 | US20050260669 Antibodies to iron regulating protein -2 (IRP-2) as a diagnostic for neurodegenerative disease |
| 11/24/2005 | US20050260657 Molecular entity for controlling a calcium |
| 11/24/2005 | US20050260644 Cell signaling proteins |
| 11/24/2005 | US20050260642 CNGH0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use |
| 11/24/2005 | US20050260632 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/24/2005 | US20050260622 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/24/2005 | US20050260608 Analyzing nucleic acid sample to determine presence of polymorphic variant (guanine) |
| 11/24/2005 | US20050260604 Antigens derived from the core protein of the human mammary epithelial mucin |
| 11/24/2005 | US20050260599 Nucleic acid and amino acid sequences of sweet taste receptors comprising two heterologous G-protein coupled receptor polypeptides; screening for modulators; probes for the identification of taste cells |
| 11/24/2005 | US20050260589 Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide |
| 11/24/2005 | US20050260581 Gonococcal proteins and nucleic acids |
| 11/24/2005 | US20050260579 TGF-beta type receptor cDNAs encoded products |
| 11/24/2005 | US20050260566 such as cervical cancer, independent of the patient's human papilloma virus (HPV) infection status by detecting biomarker(s) selectively overexpressed in high-grade cervical disease; immunocytochemistry or PCR; kits; biomarker such as Minichromosome maintenance (MCM) proteins |
| 11/24/2005 | US20050260565 contacting in vitro a sample comprising chemokine 88C receptor with a putative ligand, detecting binding of the 88C receptor and the putative ligand; increase in 88C signal transduction activity indicates the ligand is an activator, a decreasein transduction activity indicates the ligand is an inhibitor |
| 11/24/2005 | US20050260224 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 11/24/2005 | US20050260220 first component is the modified antigenic ectodomain of measles virus hemagglutinin protein, second component fused to first component that binds a surface protein of human immunodeficiency virus; for treating HIV infection and other therapeutic targets against which it is difficult to develop vaccines |
| 11/24/2005 | US20050260219 Carboxypeptidases B from anopheles gambiae. compositions comprising them, vaccine applications and use as therapeutical targets |
| 11/24/2005 | US20050260215 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 11/24/2005 | US20050260214 Composition and method for introduction of RNA interference sequences into targeted cells and tissues |
| 11/24/2005 | US20050260213 Fcgamma-RIIB-specific antibodies and methods of use thereof |
| 11/24/2005 | US20050260212 Expressed in the stroma surrounding the cancer tumor, targeting the tumor stroma via anti-LFL2 therapy can decrease the tumor interstitial fluid pressure (IFP), resulting in greater blood flow to the tumor and more efficient chemotherapeutic drug delivery or delivery of other molecular therapy |
| 11/24/2005 | US20050260210 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation |
| 11/24/2005 | US20050260209 Ephrin-b receptor protein involved in carcinoma |
| 11/24/2005 | US20050260208 Binding agents and their use in targeting tumor cells |
| 11/24/2005 | US20050260207 Monoclonal antibody neutralising cathepsin b activity and uses thereof |
| 11/24/2005 | US20050260206 Drugs containing genetically modified antibody against ganglioside gd3 |
| 11/24/2005 | US20050260205 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens and therapy thereof |
| 11/24/2005 | US20050260204 interleukin-9 (IL-9); exhibit stability, low to undetectable levels of aggregation; storage stability; autoimmune, inflammatory, proliferative, respiratory diseases |
| 11/24/2005 | US20050260202 Methods for producing proliferating muscle cells |
| 11/24/2005 | US20050260201 Methods of treating rheumatoid arthritis using anti-TNF receptor fusion proteins |
| 11/24/2005 | US20050260200 Antigenic peptides reacting with anti-ovary antibodies |
| 11/24/2005 | US20050260199 For inhibition of viral entry into cells; purified antibodies |
| 11/24/2005 | US20050260198 Inhibition of factor B, the alternative complement pathway and methods related thereto |
| 11/24/2005 | US20050260197 Receptor for Oncostatin M |
| 11/24/2005 | US20050260196 Method of treating cancer and identifying novel anti-cancer compounds |
| 11/24/2005 | US20050260195 Treatment of hepatitis B virus infection with human monoclonal antibodies |
| 11/24/2005 | US20050260194 Immunoglobulin chimeric monomer-dimer hybrids |
| 11/24/2005 | US20050260193 Steroid sparing agents and methods of using same |
| 11/24/2005 | US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents |
| 11/24/2005 | US20050260191 for determining bioactive intact PTH levels in serum, plasma, and/or cell culture media; have a novel recognition for amino acid residues extending beyond the first N-terminal PTH residue; have binding affinity and specificity for PTH that have mitigated cross-reactivity to large non (1-84) PTH fragments |
| 11/24/2005 | US20050260190 Therapeutic agent for iNOS generating illness |
| 11/24/2005 | US20050260177 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 11/24/2005 | US20050260132 Monoclonal antibodies directed to receptor protein tyrosine phosphatase zeta |
| 11/24/2005 | US20050259281 Method, apparatus and computer program for transforming digital colour images |